PathXL annouces Automated Tumor Cell Counting on Digital H&E Slides

PathXL Announces Automated Tumor Cell Counting on Digital H&E Slides

PathXL today announced it will unveil a significant upgrade to its award-winning product, TissueMark®, which will now include a powerful add-on for cell counting. The formal announcement will take place at the forthcoming Global Engage Digital Pathology Congress, to be held in London on Dec 4th and 5th, where PathXL’s founder and VP for R&D, Professor Peter Hamilton, will be giving a detailed presentation.

TissueMark will now include a powerful add-on for cell counting


The tumor cell counting capability is powered by PathXL’s Tissue Recognition Engine™ and is an extension to PathXL’s current TissueMark range, designed for the rapid and automated detection and analysis of tumor tissue on digitized, H&E stained tissue samples.

“Automated tumor cell counting is one of the most sought after applications in the field of digital imaging,” said Des Speed, CEO of PathXL. “I’m proud of the work our team have done here in bringing together several different approaches to crack this problem. The new TissueMark product will prove hugely valuable to those labs that need to feed accurate tumor content information into the molecular pathology process and for those wishing to establish strong quality and audit trails”

Macrogen Selects GenoLogics’ Clarity LIMS to Strengthen X-Genome and Clinical Sequencing Services

October 21, 2014

Strengthening the Support for researchers and Clinical Customers

Reinforcing the Market Leadership through the X-Genome and Clinical Sequencing Service

Seoul, South Korea and San Francisco, USA - The personalized medicine biotechnology company Macrogen (www.macrogen.com) has announced it has licensed Clarity LIMS from GenoLogics Life Sciences Software (www.genologics.com), a leading provider of LIMS specifically designed for omics labs, to support its whole-genome sequencing and clinical sequencing services.

Read more here: Genologics News

Photos from the AGTA Conference

OnQ Software recently attended the annual AGTA conference. Check out some of the photos we took below!

If you would like any information on the products that were on show, please don't hesitate to contact us. 

Thanks to all who came and visited!

Illumina Selects GenoLogics' LIMS Software to Support HiSeq Customers

NEW YORK (GenomeWeb) – GenoLogics said today that Illumina has selected its Clarity laboratory information management system (LIMS) as the preferred software for customers of its HiSeq X Ten sequencing platform.

With this announcement, GenoLogics makes good on a promise it made earlier this year that an upcoming release of Clarity would include support for the HiSeq X Ten. Together, the companies are currently working on support for HiSeq X Ten whole-genome workflows and analysis pipelines, including those that will be used inside of Illumina, GenoLogics said. Additionally, Illumina will use Clarity to support its collaboration with Genomics England to sequence 100,000 genomes.

"Illumina is pleased to be working with GenoLogics to ensure HiSeq X Ten customers receive the LIMS support they need," Alex Dickinson, Illumina's senior vice president of strategic initiatives, said in a statement. "Scaling a lab to deliver the $1,000 genome presents unique challenges and GenoLogics has the demonstrated ability and understanding of our technologies to support these labs."

GenoLogics' Clarity already supports Illumina's TruSight individual genome sequencing test as well as its HiSeq, MiSeq, and Genome Analyzer sequencers.

Source - GenomeWeb Daily News

Gaining Clarity - GenoLogics Clarity LIMS UGM

Clarity LIMS User Group Meeting

October 22nd, 2014. San Diego, CA

Registration for the UGM is now open and free! Please visit GenoLogics' website to register. 

http://genologics.com/gaining-clarity

14th annual conference of the Australasian Genomic Technologies Association

OnQ Software will be attending the annual AGTA conference this year between the 12th and 15th October. 

Come see as at booth No. 18


The AGTA conference (formerly known as AMATA) is Australia’s foremost genomic technology conference. It is an essential event for researchers and industry representatives who work with genomic technologies in a variety of contexts including platform development, medical genomics, functional genomics, non-model systems, epigenomics and plant genomics. The conference also offers an important opportunity for computational biologists, bioinformaticians and data visualisation specialists to interact with technologists and biologists. This unique mix is one of the reasons that the Australian genomics community has a dynamic cross-disciplinary and innovative approach to genomic analysis, and is at the forefront of analysis tools for new types of ‘omics data.

Bio21 Morning Tea

OnQ Software recently attended the Bio21 Morning Tea. It was a great morning with lots of yummy treats for the attendees! 

For more information regarding the solutions OnQ Software exhibited, please head to www.onqsoft.com.au/products.html

IAP Conference 2014 Photos

OnQ Software recently attended the IAP conference to showcase the Noemalife product range. Along side Managing Director Nick Gannoulis was Federico Falcioni who travelled from Noemalife's head office in Italy.

If you have any further qustions regarding the products that were exhibited at the conference, please contact us at info@onqsoft.com.au. The Noemalife product range can be seen on our website at www.onqsoft.com.au/noemalifeproduct.html

WCTB7 Conference 2014 - Photos

Here are some quick photos from the first day of the World Congress on Tissue Banking Conference here in Melbourne

Upcoming Conferences

OnQ Software will be attending the the following upcoming conferences

The 7th World Congress on Tissue Banking 2014. 

http://www.wctb2014.com/

        

12th - 14th  May 2014

International Academy of Pathology Conference

39th Annual Scientific Meeting.
Brisbane Convention Centre, South Bank,
Brisbane, Australia.

May 30 - 1st June 2014

MEDLAB Conference Photos!

OnQ Software recently exhibited at the MEBLAB Asia Pacific conference from the 18th to the 20th February 2014. Here are some photos of the booth!

Bluechiip signs Australian distribution agreement with OnQ Software

Bluechiip Limited (ASX: BCT) today announced that it has entered into an exclusive Distribution Agreement with OnQ to sell Bluechiip products as part of their QLIMS software solution that integrates the Bluechiip chain-of-custody and temperature tracking for Australia and New Zealand. The scope of the agreement includes the biotechnology, pharmaceutical, academic, clinical, governmental, healthcare, industrial and environmental markets.

Bluechiip’s sample chain-of-custody and temperature capability together with OnQ Software’s QLIMS product provides an end-to-end tracking solution that is not otherwise available.

Bluechiip Limited Acting CEO Jason Chaffey said “This distribution agreement is a logical next step after completing the software integration project and we are proud to be working with an innovative company such as OnQ.”

Nick Gannoulis, Managing Director of OnQ said “This agreement between Bluechiip and OnQ is another example of two technology partners working together to provide a comprehensive solution for our customers and we will be pleased to promote this new integrated product with our existing and new customers over the coming year.”

Clarity LIMS to Support Illumina HiSeq X™ Ten

GenoLogics works with Garvan Institute of Medical Research to support cutting edge sequencing platform

Victoria, B.C. – January 29, 2014 – GenoLogics Life Sciences Software, a leading provider of laboratory information management systems (LIMS) specifically designed for omics labs, announced today that the coming release of Clarity LIMS will support next generation sequencing workflows and integrations for the Illumina HiSeq X™ Ten. The functionality will be used and beta-tested by the Garvan Institute of Medical Research in Sydney Australia.

Garvan, a Clarity LIMS customer since early 2013 and a HiSeq X™ Ten customer, will provide feeback on the LIMS functionality tailored for the HiSeq X™ Ten prior to the general release of the insturment support currently slated for March 2014.

“We are excited to support this groundbreaking platform from Illumina,” remarks Michael Ball, CEO of GenoLogics. “ We have enjoyed a unique relationship with Illumina for a number of years, leading to jointly developed LIMS integrations for all Illumina sequencers. Since Clarity LIMS is already installed in some of the largest genomics labs in the world, the HiSeq X™ Ten is an obvious next step in our support of Illumina customers.”

    

More information about the Clarity LIMS support for the HiSeqX™ Ten insturment will be presented at the

Advances in Genome Biology & Technology (AGBT) meeting next month.

About GenoLogics

GenoLogics is a leading provider of laboratory information management system (LIMS) software specifically designed for genomics and mass spec research in regulated and unregulated labs. Its recently introduced Clarity LIMS offers an intuitive role-optimized interface and features that make it an invaluable investment for labs that are regulated or CLIA-certified and have NGS technologies. Founded in 2002, GenoLogics is uniquely qualified to meet the current and future lab information management needs of modern genomics and mass spec research laboratories. Privately held GenoLogics is based

in Victoria, British Columbia. More information at www.genologics.com.

About the Garvan Institute of Medical Research

The Garvan Institute of Medical Research is one of Australia's largest medical research institutions with over 600 scientists, students and support staff. Garvan's main research areas are: Cancer, Diabetes & Obesity, Immunology and Inflammation, Osteoporosis and Bone Biology and Neuroscience. Garvan's mission is to make significant contributions to medical science that will change the directions of science and medicine and have major impacts on human health. The outcome of Garvan's discoveries is the development of better methods of diagnosis, treatment, and ultimately, prevention of disease.